Delivery Order SPE2DE21D7001-SPE2D625F0RAB
- Not listed
- Medtronic Inc., through its Medtronic USA, Inc. division, was awarded a delivery order valued at $4,240.80 on July 24, 2025, by the Defense Health Agency's Medical Supply Chain for biologics identified as DBM-TS-GRAFTON DBF. This fixed-price delivery order with economic price adjustment provisions will be performed in Fridley, Minnesota and is scheduled for ultimate completion by July 25, 2025. The award was made without a set-aside designation through full and open competition, reflecting...
- Medtronic Inc., through its Medtronic USA, Inc. division, was awarded a delivery order valued at $2,875.65 by the Defense Health Agency's Medical Supply Chain on August 7, 2025, for biologics identified as DBM-TS-OTI Grafton DBM Matrix. The contract utilizes a fixed-price pricing structure with economic price adjustment provisions and carries an ultimate completion date of August 11, 2025. Performance will be executed in Fridley, Minnesota. This delivery order was not issued under any small...
- Medtronic Inc., a global medical technology company, has been awarded a Delivery Order contract by the Defense Logistics Agency Troop Support Medical valued at $2,875.65. The contract is for the provision of Biologics - DBM-TS-OTI Grafton DBM Matrix, a surgical implant product. This order is not designated as a set-aside contract. The contract has a completion date of February 8, 2024 and was awarded on February 5, 2024. Medtronic Inc. has a long history of supplying medical devices and...
- The U.S. government has awarded a $5,702.85 fixed-price delivery order contract to Medtronic Inc., through its Medtronic USA, Inc. division, for the supply of Biologics - DBM-TS-OTI Grafton DBM Matrix medical products. This contract was awarded by the Defense Health Agency (DHA), a component of the Department of Defense (DoD) that oversees the Military Health System. The contract has an ultimate completion date of December 9, 2024 and does not have a set-aside designation. Medtronic is a...
- This is a $6,098.05 firm fixed-price delivery order awarded by the Defense Health Agency (DHA) to Medtronic Inc., a global medical technology company, for the supply of biologics - DBM-TS-OTI Grafton Plus DBM. The contract has no set-aside designation, indicating full and open competition. Medtronic Inc. is the prime contractor, and the contract has an ultimate completion date of February 26, 2025. This award is part of Medtronic's extensive portfolio of federal contract awards, particularly...
- Medtronic Inc., a global medical technology company, was awarded a $5,702.85 fixed-price delivery order contract by the Defense Logistics Agency Troop Support Medical to provide Biologics - DBM-TS-OTI Grafton DBM Matrix medical devices. The contract has a performance period through March 13, 2023 and does not utilize a set-aside designation. Medtronic is the prime contractor and will manufacture and deliver the products to the Spring Lake Park, Minnesota location. This award is part of...
- The U.S. government agency, the Defense Health Agency (DHA), awarded a $1,516.20 fixed-price with economic price adjustment delivery order contract to Medtronic Inc., through its Medtronic USA, Inc. division, to provide biologics - DBM-TS-GRAFTON DBF. This contract has an ultimate completion date of October 15, 2024. Medtronic is a global medical technology company that specializes in developing and manufacturing innovative medical devices and therapies. The company has a significant...
- Medtronic Inc., a global medical technology company, was awarded a $19,418.00 fixed-price delivery order contract by the Defense Logistics Agency Troop Support Medical to provide Biologics - DBM-TS-Grafton DBF products. The contract does not have a set-aside designation and has a completion date of February 29, 2024. Medtronic is the prime contractor for this order, which is part of a larger $600 million Indefinite Delivery Contract the company holds with the U.S. Department of Veterans...
- Medtronic Inc., through its Medtronic USA division, was awarded a delivery order valued at $9,753.65 on July 31, 2025, for the supply of Biologics—Synthetics MasterGraft Strip, a specialized medical product. The contract is a fixed-price agreement with economic price adjustment provisions and will be performed in Fridley, Minnesota, with an ultimate completion date of August 7, 2025. This delivery order was awarded without set-aside designation through the Defense Health Agency's Medical...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a $2,613.45 fixed-price delivery order to Medtronic Inc., a global medical technology company, for the delivery of BIOLOGICS - DBM-TS-OTI GRAFTON DBM PUTTY medical devices. This award is part of Medtronic's role as a prime vendor providing a variety of medical devices and equipment to the Department of Veterans Affairs (VA) and Defense Health Agency (DHA) under federal contracts. Medtronic has an active Indefinite Delivery...
- SPE2DE21D7001Indefinite Delivery Contract
- SPE2DE21D7001-SPE2D625F0RABDelivery Order
Medtronic Inc., through its Medtronic USA, Inc. division, was awarded a delivery order contract valued at $1,742.30 for biologics designated as DBM-TS-OTI Grafton Plus DBM on August 11, 2025. This fixed-price contract with economic price adjustment provisions is being performed in Fridley, Minnesota and was funded by the Defense Health Agency's Medical Supply Chain. The award utilized full and open competition with no set-aside designation, reflecting Medtronic's established competitive standing as a critical supplier of advanced medical technologies to federal healthcare agencies. This delivery order represents a continuation of Medtronic's substantial federal contract portfolio supporting Department of Defense healthcare initiatives. The contract deliverable—Grafton Plus DBM, an advanced biological product—aligns with Medtronic's core competencies in providing specialized medical devices and biologics to the Defense Health Agency and Veterans Affairs. The ultimate completion date is scheduled for August 12, 2025, with the modest ceiling value reflecting the specific quantity of biologics required under this particular task order within the broader contracting relationship between Medtronic and the federal healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/11/25 |